INS and metabolic dysfunction-associated steatotic liver disease: In individuals with NAFLD, ceramide content was not increased (while DAG was increased) [50], and there were no apparent associations between liver ceramide content and insulin sensitivity or HOMA-IR in any of the associative studies [47,48,49].